Arvind Ramanlal Patel, MD | |
3264 N Evergreen Drive Ne, Grand Rapids, MI 49525-2413 | |
(616) 363-7272 | |
(616) 361-5828 |
Full Name | Arvind Ramanlal Patel |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 36 Years |
Location | 3264 N Evergreen Drive Ne, Grand Rapids, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245225499 | NPI | - | NPPES |
036098729 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 4301082344 (Michigan) | Primary |
2085R0202X | Radiology - Diagnostic Radiology | 036098729 (Illinois) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Spectrum Health | Grand rapids, MI | Hospital |
Covenant Medical Center | Saginaw, MI | Hospital |
Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
Midmichigan Medical Center-midland | Midland, MI | Hospital |
Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Advanced Radiology Services Pc | 4284546516 | 235 |
Spartan Radiology Inc | 5698003697 | 179 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | Advanced Radiology Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740283324 PECOS PAC ID: 4284546516 Enrollment ID: O20031104000494 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | Advanced Diagnostic Imaging Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245299494 PECOS PAC ID: 3779489224 Enrollment ID: O20031208000473 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | Covenant Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972590412 PECOS PAC ID: 2769387778 Enrollment ID: O20031209000107 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | Great Lakes Bay Health Centers |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871684761 PECOS PAC ID: 2466369046 Enrollment ID: O20040126000171 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | North Oakland North Macomb Imaging Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407842586 PECOS PAC ID: 3476526963 Enrollment ID: O20040813000422 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | Ascension Borgess Lee Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194771030 PECOS PAC ID: 7719881002 Enrollment ID: O20060228000470 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Entity Name | Spartan Radiology Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932768058 PECOS PAC ID: 5698003697 Enrollment ID: O20190829001596 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Arvind Ramanlal Patel, MD 3264 N Evergreen Drive Ne, Grand Rapids, MI 49525 Ph: (616) 363-7272 | Arvind Ramanlal Patel, MD 3264 N Evergreen Drive Ne, Grand Rapids, MI 49525-2413 Ph: (616) 363-7272 |
News Archive
Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Researchers at the San Raffaele Hospital (Milan, Italy) published unexpected results of studies in which immature nerve cells (adult mouse neural stem cells) injected into the blood of mice with MS-like disease were able to suppress the immune attacks that damage the brain and spinal cord tissues.
DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.
› Verified 5 days ago
Dr. Jon R Henke, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Geoffrey M. Remes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Jan L Mourelatos, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-361-5828 | |
Dr. Brendan Michael Banyon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 | |
Dr. Joseph J Junewick, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Keith Alan Morrow, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Dr. Andrew Kent Moriarity, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 |